Concepedia

Richard E. Higgs

RE

Statistics

Publications

57

Citations

6.1K

H-Index

35

Active since

1992

Affiliations

Eli Lilly (United States)(Current)

Imperial College London

Cedars-Sinai Medical Center

Lung Institute

University of North Carolina at Chapel Hill

Richard E. Higgs is an author at Eli Lilly (United States) specializing in medicine, natural sciences, and biochemistry.

ORCID

Top concepts

Publications per year

1992–2024

57

Publications

57

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

Robert Gottlieb, Ajay Nirula, Peter Chen et al. · JAMA · 2021 · 931 citations · Full text

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Milla Koistinaho, Suizhen Lin, Xin Wu et al. · Nature Medicine · 2004 · 555 citations

, , +9

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 484 citations · Full text

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 452 citations · Full text

Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs

Michal Vieth, Miles G. Siegel, Richard E. Higgs et al. · Journal of Medicinal Chemistry · 2003 · 355 citations

, , +15

1–5 of 57